1 Report Overview 1.1 Research Scope 1.2 Market Segment by Type 1.2.1 Global Poliovirus Vaccine Market Size Growth Rate by Type (2017 VS 2021 VS 2028) 1.2.2 Inactivated Polio Vaccine (IPV) 1.2.3 Oral Polio Vaccine (OPV) 1.3 Market Segment by Application 1.3.1 Global Poliovirus Vaccine Market Share by Application (2017 VS 2021 VS 2028) 1.3.2 Public 1.3.3 Private 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Poliovirus Vaccine Market Size (2017-2028) 2.1.1 Global Poliovirus Vaccine Revenue (2017-2028) 2.1.2 Global Poliovirus Vaccine Sales (2017-2028) 2.2 Global Poliovirus Vaccine Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.2.1 Global Poliovirus Vaccine Sales by Regions (2017-2022) 2.2.2 Global Poliovirus Vaccine Revenue by Regions (2017-2022) 2.3 Global Poliovirus Vaccine Market Size Forecast by Region 2.3.1 Global Poliovirus Vaccine Sales Forecast by Region (2023-2028) 2.3.2 Global Poliovirus Vaccine Revenue Forecast by Region (2023-2028) 2.4 Global Top Poliovirus Vaccine Regions (Countries) Ranking by Market Size 2.5 Poliovirus Vaccine Market Dynamics 2.5.1 Poliovirus Vaccine Market Trends 2.5.2 Poliovirus Vaccine Market Drivers 2.5.3 Poliovirus Vaccine Market Challenges 2.5.4 Poliovirus Vaccine Market Restraints 3 Competitive Landscape by Manufacturers 3.1 Global Top Poliovirus Vaccine Manufacturers by Sales (2017-2022) 3.1.1 Global Poliovirus Vaccine Sales by Manufacturers (2017-2022) 3.1.2 Global Poliovirus Vaccine Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global 5 and 10 Largest Manufacturers by Poliovirus Vaccine Sales in 2021 3.2 Global Top Manufacturers Poliovirus Vaccine by Revenue 3.2.1 Global Poliovirus Vaccine Revenue by Manufacturers (2017-2022) 3.2.2 Top Poliovirus Vaccine Manufacturers Covered: Ranking by Revenue 3.2.3 Global Poliovirus Vaccine Revenue Share by Manufacturers (2017-2022) 3.2.4 Global Poliovirus Vaccine Market Concentration Ratio (CR5 and HHI) 3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Poliovirus Vaccine as of 2021) 3.4 Global Poliovirus Vaccine Average Selling Price (ASP) by Manufacturers 3.5 Key Manufacturers Poliovirus Vaccine Plants/Factories Distribution and Area Served 3.6 Date of Key Manufacturers Enter into Poliovirus Vaccine Market 3.7 Key Manufacturers Poliovirus Vaccine Product Offered 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Poliovirus Vaccine Market Size by Type 4.1 Global Poliovirus Vaccine Historic Market Review by Type (2017-2022) 4.1.1 Global Poliovirus Vaccine Sales Market Share by Type (2017-2022) 4.1.2 Global Poliovirus Vaccine Revenue Market Share by Type (2017-2022) 4.1.3 Poliovirus Vaccine Price by Type (2017-2022) 4.2 Global Poliovirus Vaccine Market Estimates and Forecasts by Type (2023-2028) 4.2.1 Global Poliovirus Vaccine Sales Forecast by Type (2023-2028) 4.2.2 Global Poliovirus Vaccine Revenue Forecast by Type (2023-2028) 4.2.3 Poliovirus Vaccine Price Forecast by Type (2023-2028) 5 Global Poliovirus Vaccine Market Size by Application 5.1 Global Poliovirus Vaccine Historic Market Review by Application (2017-2022) 5.1.1 Global Poliovirus Vaccine Sales Market Share by Application (2017-2022) 5.1.2 Global Poliovirus Vaccine Revenue Market Share by Application (2017-2022) 5.1.3 Poliovirus Vaccine Price by Application (2017-2022) 5.2 Global Poliovirus Vaccine Market Estimates and Forecasts by Application (2023-2028) 5.2.1 Global Poliovirus Vaccine Sales Forecast by Application (2023-2028) 5.2.2 Global Poliovirus Vaccine Revenue Forecast by Application (2023-2028) 5.2.3 Poliovirus Vaccine Price Forecast by Application (2023-2028) 6 North America 6.1 North America Poliovirus Vaccine Sales Breakdown by Company 6.1.1 North America Poliovirus Vaccine Sales by Company (2017-2022) 6.1.2 North America Poliovirus Vaccine Revenue by Company (2017-2022) 6.2 North America Poliovirus Vaccine Market Size by Type 6.2.1 North America Poliovirus Vaccine Sales by Type (2017-2028) 6.2.2 North America Poliovirus Vaccine Revenue by Type (2017-2028) 6.3 North America Poliovirus Vaccine Market Size by Application 6.3.1 North America Poliovirus Vaccine Sales by Application (2017-2028) 6.3.2 North America Poliovirus Vaccine Revenue by Application (2017-2028) 6.4 North America Poliovirus Vaccine Market Size by Country 6.4.1 North America Poliovirus Vaccine Sales by Country (2017-2028) 6.4.2 North America Poliovirus Vaccine Revenue by Country (2017-2028) 6.4.3 the United States 6.4.4 Canada 7 Europe 7.1 Europe Poliovirus Vaccine Sales Breakdown by Company 7.1.1 Europe Poliovirus Vaccine Sales by Company (2017-2022) 7.1.2 Europe Poliovirus Vaccine Revenue by Company (2017-2022) 7.2 Europe Poliovirus Vaccine Market Size by Type 7.2.1 Europe Poliovirus Vaccine Sales by Type (2017-2028) 7.2.2 Europe Poliovirus Vaccine Revenue by Type (2017-2028) 7.3 Europe Poliovirus Vaccine Market Size by Application 7.3.1 Europe Poliovirus Vaccine Sales by Application (2017-2028) 7.3.2 Europe Poliovirus Vaccine Revenue by Application (2017-2028) 7.4 Europe Poliovirus Vaccine Market Size by Country 7.4.1 Europe Poliovirus Vaccine Sales by Country (2017-2028) 7.4.2 Europe Poliovirus Vaccine Revenue by Country (2017-2028) 7.4.3 Germany 7.4.4 France 7.4.5 UK 7.4.6 Italy 7.4.7 Russia 8 Asia Pacific 8.1 Asia Pacific Poliovirus Vaccine Sales Breakdown by Company 8.1.1 Asia Pacific Poliovirus Vaccine Sales by Company (2017-2022) 8.1.2 Asia Pacific Poliovirus Vaccine Revenue by Company (2017-2022) 8.2 Asia Pacific Poliovirus Vaccine Market Size by Type 8.2.1 Asia Pacific Poliovirus Vaccine Sales by Type (2017-2028) 8.2.2 Asia Pacific Poliovirus Vaccine Revenue by Type (2017-2028) 8.3 Asia Pacific Poliovirus Vaccine Market Size by Application 8.3.1 Asia Pacific Poliovirus Vaccine Sales by Application (2017-2028) 8.3.2 Asia Pacific Poliovirus Vaccine Revenue by Application (2017-2028) 8.4 Asia Pacific Poliovirus Vaccine Market Size by Region 8.4.1 Asia Pacific Poliovirus Vaccine Sales by Region 8.4.2 Asia Pacific Poliovirus Vaccine Revenue by Region 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 India 8.4.7 Australia 8.4.8 China Taiwan 8.4.9 Indonesia 8.4.10 Thailand 8.4.11 Malaysia 9 Latin America 9.1 Latin America Poliovirus Vaccine Sales Breakdown by Company 9.1.1 Latin America Poliovirus Vaccine Sales by Company (2017-2022) 9.1.2 Latin America Poliovirus Vaccine Revenue by Company (2017-2022) 9.2 Latin America Poliovirus Vaccine Market Size by Type 9.2.1 Latin America Poliovirus Vaccine Sales by Type (2017-2028) 9.2.2 Latin America Poliovirus Vaccine Revenue by Type (2017-2028) 9.3 Latin America Poliovirus Vaccine Market Size by Application 9.3.1 Latin America Poliovirus Vaccine Sales by Application (2017-2028) 9.3.2 Latin America Poliovirus Vaccine Revenue by Application (2017-2028) 9.4 Latin America Poliovirus Vaccine Market Size by Country 9.4.1 Latin America Poliovirus Vaccine Sales by Country (2017-2028) 9.4.2 Latin America Poliovirus Vaccine Revenue by Country (2017-2028) 9.4.3 Mexico 9.4.4 Brazil 9.4.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Poliovirus Vaccine Sales Breakdown by Company 10.1.1 Middle East and Africa Poliovirus Vaccine Sales by Company (2017-2022) 10.1.2 Middle East and Africa Poliovirus Vaccine Revenue by Company (2017-2022) 10.2 Middle East and Africa Poliovirus Vaccine Market Size by Type 10.2.1 Middle East and Africa Poliovirus Vaccine Sales by Type (2017-2028) 10.2.2 Middle East and Africa Poliovirus Vaccine Revenue by Type (2017-2028) 10.3 Middle East and Africa Poliovirus Vaccine Market Size by Application 10.3.1 Middle East and Africa Poliovirus Vaccine Sales by Application (2017-2028) 10.3.2 Middle East and Africa Poliovirus Vaccine Revenue by Application (2017-2028) 10.4 Middle East and Africa Poliovirus Vaccine Market Size by Country 10.4.1 Middle East and Africa Poliovirus Vaccine Sales by Country (2017-2028) 10.4.2 Middle East and Africa Poliovirus Vaccine Revenue by Country (2017-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Company Profiles 11.1 Sanofi 11.1.1 Sanofi Corporation Information 11.1.2 Sanofi Overview 11.1.3 Sanofi Poliovirus Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.1.4 Sanofi Poliovirus Vaccine Products and Services 11.1.5 Sanofi Poliovirus Vaccine SWOT Analysis 11.1.6 Sanofi Recent Developments 11.2 GSK 11.2.1 GSK Corporation Information 11.2.2 GSK Overview 11.2.3 GSK Poliovirus Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.2.4 GSK Poliovirus Vaccine Products and Services 11.2.5 GSK Poliovirus Vaccine SWOT Analysis 11.2.6 GSK Recent Developments 11.3 Bibcol 11.3.1 Bibcol Corporation Information 11.3.2 Bibcol Overview 11.3.3 Bibcol Poliovirus Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.3.4 Bibcol Poliovirus Vaccine Products and Services 11.3.5 Bibcol Poliovirus Vaccine SWOT Analysis 11.3.6 Bibcol Recent Developments 11.4 Serum Institute 11.4.1 Serum Institute Corporation Information 11.4.2 Serum Institute Overview 11.4.3 Serum Institute Poliovirus Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.4.4 Serum Institute Poliovirus Vaccine Products and Services 11.4.5 Serum Institute Poliovirus Vaccine SWOT Analysis 11.4.6 Serum Institute Recent Developments 11.5 Tiantan Biological 11.5.1 Tiantan Biological Corporation Information 11.5.2 Tiantan Biological Overview 11.5.3 Tiantan Biological Poliovirus Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.5.4 Tiantan Biological Poliovirus Vaccine Products and Services 11.5.5 Tiantan Biological Poliovirus Vaccine SWOT Analysis 11.5.6 Tiantan Biological Recent Developments 11.6 IMBCA 11.6.1 IMBCA Corporation Information 11.6.2 IMBCA Overview 11.6.3 IMBCA Poliovirus Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.6.4 IMBCA Poliovirus Vaccine Products and Services 11.6.5 IMBCA Poliovirus Vaccine SWOT Analysis 11.6.6 IMBCA Recent Developments 11.7 Panacea Biotec Ltd 11.7.1 Panacea Biotec Ltd Corporation Information 11.7.2 Panacea Biotec Ltd Overview 11.7.3 Panacea Biotec Ltd Poliovirus Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.7.4 Panacea Biotec Ltd Poliovirus Vaccine Products and Services 11.7.5 Panacea Biotec Ltd Poliovirus Vaccine SWOT Analysis 11.7.6 Panacea Biotec Ltd Recent Developments 11.8 Bio-Med 11.8.1 Bio-Med Corporation Information 11.8.2 Bio-Med Overview 11.8.3 Bio-Med Poliovirus Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.8.4 Bio-Med Poliovirus Vaccine Products and Services 11.8.5 Bio-Med Poliovirus Vaccine SWOT Analysis 11.8.6 Bio-Med Recent Developments 11.9 Halfkin Bio-Pharmaceuticals 11.9.1 Halfkin Bio-Pharmaceuticals Corporation Information 11.9.2 Halfkin Bio-Pharmaceuticals Overview 11.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022) 11.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Products and Services 11.9.5 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine SWOT Analysis 11.9.6 Halfkin Bio-Pharmaceuticals Recent Developments 12 Value Chain and Sales Channels Analysis 12.1 Poliovirus Vaccine Value Chain Analysis 12.2 Poliovirus Vaccine Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Poliovirus Vaccine Production Mode & Process 12.4 Poliovirus Vaccine Sales and Marketing 12.4.1 Poliovirus Vaccine Sales Channels 12.4.2 Poliovirus Vaccine Distributors 12.5 Poliovirus Vaccine Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Global Poliovirus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million) Table 2. Major Manufacturers of Inactivated Polio Vaccine (IPV) Table 3. Major Manufacturers of Oral Polio Vaccine (OPV) Table 4. Global Poliovirus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million) Table 5. Global Poliovirus Vaccine Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028 Table 6. Global Poliovirus Vaccine Sales by Region (2017-2022) & (K Units) Table 7. Global Poliovirus Vaccine Sales Market Share by Region (2017-2022) Table 8. Global Poliovirus Vaccine Revenue by Region (2017-2022) & (US$ Million) Table 9. Global Poliovirus Vaccine Revenue Market Share by Region (2017-2022) Table 10. Global Poliovirus Vaccine Sales Forecast by Region (2023-2028) & (K Units) Table 11. Global Poliovirus Vaccine Sales Market Share Forecast by Region (2023-2028) Table 12. Global Poliovirus Vaccine Revenue Forecast by Region (2023-2028) & (US$ Million) Table 13. Global Poliovirus Vaccine Revenue Market Share Forecast by Region (2023-2028) Table 14. Top Poliovirus Vaccine Regions (Countries) Ranking by Market Size (US$ Million) in 2021 Table 15. Poliovirus Vaccine Market Trends Table 16. Poliovirus Vaccine Market Drivers Table 17. Poliovirus Vaccine Market Challenges Table 18. Poliovirus Vaccine Market Restraints Table 19. Global Poliovirus Vaccine Sales by Manufacturers (2017-2022) & (K Units) Table 20. Global Poliovirus Vaccine Sales Share by Manufacturers (2017-2022) Table 21. Global Poliovirus Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million) Table 22. Ranking of Global Top Poliovirus Vaccine Manufacturers by Revenue (US$ Million) in 2021 Table 23. Poliovirus Vaccine Revenue Share by Manufacturers (2017-2022) Table 24. Global Poliovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 25. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Poliovirus Vaccine as of 2021) Table 26. Key Manufacturers Poliovirus Vaccine Average Selling Price (ASP) & (2017-2022) & (USD/Unit) Table 27. Key Manufacturers Poliovirus Vaccine Plants/Factories Distribution Table 28. Key Manufacturers Poliovirus Vaccine Area Served Table 29. Date of Key Manufacturers Enter into Poliovirus Vaccine Market Table 30. Key Manufacturers Poliovirus Vaccine Product Type Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Poliovirus Vaccine Sales (K Units) by Type (2017-2022) Table 33. Global Poliovirus Vaccine Sales Share by Type (2017-2022) Table 34. Global Poliovirus Vaccine Revenue (US$ Million) Market Share by Type (2017-2022) Table 35. Global Poliovirus Vaccine Price (K Units) by Type (2017-2022) Table 36. Global Poliovirus Vaccine Sales (K Units) by Type (2023-2028) Table 37. Global Poliovirus Vaccine Sales Share by Type (2023-2028) Table 38. Global Poliovirus Vaccine Revenue (US$ Million) Market Share by Type (2023-2028) Table 39. Global Poliovirus Vaccine Revenue Share by Type (2023-2028) Table 40. Global Poliovirus Vaccine Price (K Units) by Type (2023-2028) Table 41. Global Poliovirus Vaccine Sales (K Units) by Application (2017-2022) Table 42. Global Poliovirus Vaccine Sales Share by Application (2017-2022) Table 43. Global Poliovirus Vaccine Revenue (US$ Million) Market Share by Application (2017-2022) Table 44. Global Poliovirus Vaccine Price (K Units) by Application (2017-2022) Table 45. Global Poliovirus Vaccine Sales (K Units) by Application (2023-2028) Table 46. Global Poliovirus Vaccine Sales Share by Application (2023-2028) Table 47. Global Poliovirus Vaccine Revenue (US$ Million) Market Share by Application (2023-2028) Table 48. Global Poliovirus Vaccine Revenue Share by Application (2023-2028) Table 49. Global Poliovirus Vaccine Price (K Units) by Application (2023-2028) Table 50. North America Poliovirus Vaccine Sales by Company (2017-2022) & (K Units) Table 51. North America Poliovirus Vaccine Sales Market Share by Company (2017-2022) Table 52. North America Poliovirus Vaccine Revenue by Company (2017-2022) & (US$ Million) Table 53. North America Poliovirus Vaccine Revenue Market Share by Company (2017-2022) Table 54. North America Poliovirus Vaccine Sales by Type (2017-2022) & (K Units) Table 55. North America Poliovirus Vaccine Sales by Type (2023-2028) & (K Units) Table 56. North America Poliovirus Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 57. North America Poliovirus Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 58. North America Poliovirus Vaccine Sales by Application (2017-2022) & (K Units) Table 59. North America Poliovirus Vaccine Sales by Application (2023-2028) & (K Units) Table 60. North America Poliovirus Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 61. North America Poliovirus Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 62. North America Poliovirus Vaccine Sales by Country (2017-2022) & (K Units) Table 63. North America Poliovirus Vaccine Sales by Country (2023-2028) & (K Units) Table 64. North America Poliovirus Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 65. North America Poliovirus Vaccine Revenue by Country (2023-2028) & (US$ Million) Table 66. Europe Poliovirus Vaccine Sales by Company (2017-2022) & (K Units) Table 67. Europe Poliovirus Vaccine Sales Market Share by Company (2017-2022) Table 68. Europe Poliovirus Vaccine Revenue by Company (2017-2022) & (US$ Million) Table 69. Europe Poliovirus Vaccine Revenue Market Share by Company (2017-2022) Table 70. Europe Poliovirus Vaccine Sales by Type (2017-2022) & (K Units) Table 71. Europe Poliovirus Vaccine Sales by Type (2023-2028) & (K Units) Table 72. Europe Poliovirus Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 73. Europe Poliovirus Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 74. Europe Poliovirus Vaccine Sales by Application (2017-2022) & (K Units) Table 75. Europe Poliovirus Vaccine Sales by Application (2023-2028) & (K Units) Table 76. Europe Poliovirus Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 77. Europe Poliovirus Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 78. Europe Poliovirus Vaccine Sales by Country (2017-2022) & (K Units) Table 79. Europe Poliovirus Vaccine Sales by Country (2023-2028) & (K Units) Table 80. Europe Poliovirus Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 81. Europe Poliovirus Vaccine Revenue by Country (2023-2028) & (US$ Million) Table 82. Asia Pacific Poliovirus Vaccine Sales by Company (2017-2022) & (K Units) Table 83. Asia Pacific Poliovirus Vaccine Sales Market Share by Company (2017-2022) Table 84. Asia Pacific Poliovirus Vaccine Revenue by Company (2017-2022) & (US$ Million) Table 85. Asia Pacific Poliovirus Vaccine Revenue Market Share by Company (2017-2022) Table 86. Asia Pacific Poliovirus Vaccine Sales by Type (2017-2022) & (K Units) Table 87. Asia Pacific Poliovirus Vaccine Sales by Type (2023-2028) & (K Units) Table 88. Asia Pacific Poliovirus Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 89. Asia Pacific Poliovirus Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 90. Asia Pacific Poliovirus Vaccine Sales by Application (2017-2022) & (K Units) Table 91. Asia Pacific Poliovirus Vaccine Sales by Application (2023-2028) & (K Units) Table 92. Asia Pacific Poliovirus Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 93. Asia Pacific Poliovirus Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 94. Asia Pacific Poliovirus Vaccine Sales by Region (2017-2022) & (K Units) Table 95. Asia Pacific Poliovirus Vaccine Sales by Region (2023-2028) & (K Units) Table 96. Asia Pacific Poliovirus Vaccine Revenue by Region (2017-2022) & (US$ Million) Table 97. Asia Pacific Poliovirus Vaccine Revenue by Region (2023-2028) & (US$ Million) Table 98. Latin America Poliovirus Vaccine Sales by Company (2017-2022) & (K Units) Table 99. Latin America Poliovirus Vaccine Sales Market Share by Company (2017-2022) Table 100. Latin America Poliovirus Vaccine Revenue by Company (2017-2022) & (US$ Million) Table 101. Latin America Poliovirus Vaccine Revenue Market Share by Company (2017-2022) Table 102. Latin America Poliovirus Vaccine Sales by Type (2017-2022) & (K Units) Table 103. Latin America Poliovirus Vaccine Sales by Type (2023-2028) & (K Units) Table 104. Latin America Poliovirus Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 105. Latin America Poliovirus Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 106. Latin America Poliovirus Vaccine Sales by Application (2017-2022) & (K Units) Table 107. Latin America Poliovirus Vaccine Sales by Application (2023-2028) & (K Units) Table 108. Latin America Poliovirus Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 109. Latin America Poliovirus Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 110. Latin America Poliovirus Vaccine Sales by Country (2017-2022) & (K Units) Table 111. Latin America Poliovirus Vaccine Sales by Country (2023-2028) & (K Units) Table 112. Latin America Poliovirus Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 113. Latin America Poliovirus Vaccine Revenue by Country (2023-2028) & (US$ Million) Table 114. Middle East and Africa Poliovirus Vaccine Sales by Company (2017-2022) & (K Units) Table 115. Middle East and Africa Poliovirus Vaccine Sales Market Share by Company (2017-2022) Table 116. Middle East and Africa Poliovirus Vaccine Revenue by Company (2017-2022) & (US$ Million) Table 117. Middle East and Africa Poliovirus Vaccine Revenue Market Share by Company (2017-2022) Table 118. Middle East and Africa Poliovirus Vaccine Sales by Type (2017-2022) & (K Units) Table 119. Middle East and Africa Poliovirus Vaccine Sales by Type (2023-2028) & (K Units) Table 120. Middle East and Africa Poliovirus Vaccine Revenue by Type (2017-2022) & (US$ Million) Table 121. Middle East and Africa Poliovirus Vaccine Revenue by Type (2023-2028) & (US$ Million) Table 122. Middle East and Africa Poliovirus Vaccine Sales by Application (2017-2022) & (K Units) Table 123. Middle East and Africa Poliovirus Vaccine Sales by Application (2023-2028) & (K Units) Table 124. Middle East and Africa Poliovirus Vaccine Revenue by Application (2017-2022) & (US$ Million) Table 125. Middle East and Africa Poliovirus Vaccine Revenue by Application (2023-2028) & (US$ Million) Table 126. Middle East and Africa Poliovirus Vaccine Sales by Country (2017-2022) & (K Units) Table 127. Middle East and Africa Poliovirus Vaccine Sales by Country (2023-2028) & (K Units) Table 128. Middle East and Africa Poliovirus Vaccine Revenue by Country (2017-2022) & (US$ Million) Table 129. Middle East and Africa Poliovirus Vaccine Revenue by Country (2023-2028) & (US$ Million) Table 130. Sanofi Corporation Information Table 131. Sanofi Description and Overview Table 132. Sanofi Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 133. Sanofi Poliovirus Vaccine Product and Services Table 134. Sanofi Poliovirus Vaccine SWOT Analysis Table 135. Sanofi Recent Developments Table 136. GSK Corporation Information Table 137. GSK Description and Overview Table 138. GSK Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 139. GSK Poliovirus Vaccine Product and Services Table 140. GSK Poliovirus Vaccine SWOT Analysis Table 141. GSK Recent Developments Table 142. Bibcol Corporation Information Table 143. Bibcol Description and Overview Table 144. Bibcol Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 145. Bibcol Poliovirus Vaccine Product and Services Table 146. Bibcol Poliovirus Vaccine SWOT Analysis Table 147. Bibcol Recent Developments Table 148. Serum Institute Corporation Information Table 149. Serum Institute Description and Overview Table 150. Serum Institute Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 151. Serum Institute Poliovirus Vaccine Product and Services Table 152. Serum Institute Poliovirus Vaccine SWOT Analysis Table 153. Serum Institute Recent Developments Table 154. Tiantan Biological Corporation Information Table 155. Tiantan Biological Description and Overview Table 156. Tiantan Biological Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 157. Tiantan Biological Poliovirus Vaccine Product and Services Table 158. Tiantan Biological Poliovirus Vaccine SWOT Analysis Table 159. Tiantan Biological Recent Developments Table 160. IMBCA Corporation Information Table 161. IMBCA Description and Overview Table 162. IMBCA Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 163. IMBCA Poliovirus Vaccine Product and Services Table 164. IMBCA Poliovirus Vaccine SWOT Analysis Table 165. IMBCA Recent Developments Table 166. Panacea Biotec Ltd Corporation Information Table 167. Panacea Biotec Ltd Description and Overview Table 168. Panacea Biotec Ltd Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 169. Panacea Biotec Ltd Poliovirus Vaccine Product and Services Table 170. Panacea Biotec Ltd Poliovirus Vaccine SWOT Analysis Table 171. Panacea Biotec Ltd Recent Developments Table 172. Bio-Med Corporation Information Table 173. Bio-Med Description and Overview Table 174. Bio-Med Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 175. Bio-Med Poliovirus Vaccine Product and Services Table 176. Bio-Med Poliovirus Vaccine SWOT Analysis Table 177. Bio-Med Recent Developments Table 178. Halfkin Bio-Pharmaceuticals Corporation Information Table 179. Halfkin Bio-Pharmaceuticals Description and Overview Table 180. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2017-2022) Table 181. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product and Services Table 182. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine SWOT Analysis Table 183. Halfkin Bio-Pharmaceuticals Recent Developments Table 184. Key Raw Materials Lists Table 185. Raw Materials Key Suppliers Lists Table 186. Poliovirus Vaccine Distributors List Table 187. Poliovirus Vaccine Customers List Table 188. Research Programs/Design for This Report Table 189. Key Data Information from Secondary Sources Table 190. Key Data Information from Primary Sources List of Figures Figure 1. Poliovirus Vaccine Product Picture Figure 2. Global Poliovirus Vaccine Sales Market Share by Type in 2021 & 2028 Figure 3. Inactivated Polio Vaccine (IPV) Product Picture Figure 4. Oral Polio Vaccine (OPV) Product Picture Figure 5. Global Poliovirus Vaccine Sales Market Share by Application in 2021 & 2028 Figure 6. Public Use Case Figure 7. Private Use Case Figure 8. Poliovirus Vaccine Report Years Considered Figure 9. Global Poliovirus Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Poliovirus Vaccine Market Size 2017-2028 (US$ Million) Figure 11. Global Poliovirus Vaccine Sales (2017-2022) & (K Units) Figure 12. Global Poliovirus Vaccine Market Size Market Share by Region: 2021 VS 2028 Figure 13. Global Poliovirus Vaccine Sales Market Share by Region (2017-2022) Figure 14. Global Poliovirus Vaccine Sales Market Share by Region in 2021 Figure 15. Global Poliovirus Vaccine Revenue Market Share by Region in 2017 VS 2021 Figure 16. Global Poliovirus Vaccine Sales Share by Manufacturers in 2021 Figure 17. The 5 and 10 Largest Manufacturers in the World: Market Share by Poliovirus Vaccine Sales in 2021 Figure 18. Poliovirus Vaccine Revenue Share by Manufacturers in 2021 Figure 19. Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 20. Global Poliovirus Vaccine Revenue Share by Type (2017-2022) Figure 21. Global Poliovirus Vaccine Revenue Growth Rate by Type in 2017 & 2021 Figure 22. Global Poliovirus Vaccine Revenue Share by Application (2017-2022) Figure 23. Global Poliovirus Vaccine Revenue Growth Rate by Application in 2017 & 2021 Figure 24. North America Poliovirus Vaccine Sales Market Share by Type (2017-2028) Figure 25. North America Poliovirus Vaccine Revenue Market Share by Type (2017-2028) Figure 26. North America Poliovirus Vaccine Sales Market Share by Application (2017-2028) Figure 27. North America Poliovirus Vaccine Revenue Market Share by Application (2017-2028) Figure 28. North America Poliovirus Vaccine Sales Share by Country (2017-2028) Figure 29. North America Poliovirus Vaccine Revenue Share by Country (2017-2028) Figure 30. the United States Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 31. Canada Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 32. Europe Poliovirus Vaccine Sales Market Share by Type (2017-2028) Figure 33. Europe Poliovirus Vaccine Revenue Market Share by Type (2017-2028) Figure 34. Europe Poliovirus Vaccine Sales Market Share by Application (2017-2028) Figure 35. Europe Poliovirus Vaccine Revenue Market Share by Application (2017-2028) Figure 36. Europe Poliovirus Vaccine Sales Share by Country (2017-2028) Figure 37. Europe Poliovirus Vaccine Revenue Share by Country (2017-2028) Figure 38. Germany Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 39. France Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 40. UK Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 41. Italy Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 42. Russia Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 43. Asia Pacific Poliovirus Vaccine Sales Market Share by Type (2017-2028) Figure 44. Asia Pacific Poliovirus Vaccine Revenue Market Share by Type (2017-2028) Figure 45. Asia Pacific Poliovirus Vaccine Sales Market Share by Application (2017-2028) Figure 46. Asia Pacific Poliovirus Vaccine Revenue Market Share by Application (2017-2028) Figure 47. Asia Pacific Poliovirus Vaccine Sales Share by Region (2017-2028) Figure 48. Asia Pacific Poliovirus Vaccine Revenue Share by Region (2017-2028) Figure 49. China Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 50. Japan Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 51. South Korea Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 52. India Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 53. Australia Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 54. China Taiwan Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 55. Indonesia Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 56. Thailand Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 57. Malaysia Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 58. Latin America Poliovirus Vaccine Sales Market Share by Type (2017-2028) Figure 59. Latin America Poliovirus Vaccine Revenue Market Share by Type (2017-2028) Figure 60. Latin America Poliovirus Vaccine Sales Market Share by Application (2017-2028) Figure 61. Latin America Poliovirus Vaccine Revenue Market Share by Application (2017-2028) Figure 62. Latin America Poliovirus Vaccine Sales Share by Country (2017-2028) Figure 63. Latin America Poliovirus Vaccine Revenue Share by Country (2017-2028) Figure 64. Mexico Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 65. Brazil Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 66. Argentina Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 67. Middle East and Africa Poliovirus Vaccine Sales Market Share by Type (2017-2028) Figure 68. Middle East and Africa Poliovirus Vaccine Revenue Market Share by Type (2017-2028) Figure 69. Middle East and Africa Poliovirus Vaccine Sales Market Share by Application (2017-2028) Figure 70. Middle East and Africa Poliovirus Vaccine Revenue Market Share by Application (2017-2028) Figure 71. Middle East and Africa Poliovirus Vaccine Sales Share by Country (2017-2028) Figure 72. Middle East and Africa Poliovirus Vaccine Revenue Share by Country (2017-2028) Figure 73. Turkey Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 74. Saudi Arabia Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 75. UAE Poliovirus Vaccine Revenue (2017-2028) & (US$ Million) Figure 76. Poliovirus Vaccine Value Chain Figure 77. Poliovirus Vaccine Production Process Figure 78. Channels of Distribution Figure 79. Distributors Profiles Figure 80. Bottom-up and Top-down Approaches for This Report Figure 81. Data Triangulation Figure 82. Key Executives Interviewed

Inactivated Polio Vaccine (IPV) Oral Polio Vaccine (OPV)